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319analogous to connective tissue disorders. This main ﬁnding is not
compromised by the heterogeneity of the literature.
The signiﬁcant heterogeneity in the literature is not restricted to
aortic stenosis and regurgitation, but also involves bicuspid aortic
valve morphologies, as well as the nature of the underlying tissue.
Indeed, we found that aortic regurgitationwas reported in an older age
groupdhad we focused on aortic valve repair publications, we would
have an entirely regurgitant population subset. Similarly, hadwe taken
a subgroup of publications from younger age groups, we would have
had a stenosis-predominant subset. Only a few authors have looked at
stenosis only (2), and hence, it was difﬁcult to compare these subsets
without the heterogeneity. An individual patient meta-analysis would
overcome the dependence of standard meta-analysis on the case-mix
of the original data, but the performance of this would require more
effective data archiving than is the current practice.
We agree that the relationship of age with aortic diameter could
be confounded by other factors (3,4). However, as those factors also
change with age, we thought that age might be a reasonable marker
to increase the clinician’s alertness. We hope that once we have
sufﬁcient longitudinal data from registry studies, these relationships
could be analyzed with more accuracy.
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Figure 1. Thirty-Day Follow-Up of Renal Function After TAVR
(A) Serum creatinine levels and group differences on day 30: *p ¼ 0.93, yp ¼ 0.44,
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Intracardiac Echo and Reduced
Radiocontrast Requirements
During TAVR
Acute kidney injury (AKI) is an independent predictor of mor-
tality after transcatheter aortic valve replacement (TAVR) (1,2)
and can be curbed by signiﬁcantly reducing the amount
of contrast agent (3). Intracardiac echocardiography (ICE) ap-
pears to match the TAVR workﬂow (4), provides the highest
image resolution, and requires only local anesthesia. It is hy-
pothesized that: 1) ICE is capable of effectively guiding TAVR,
reducing the radiocontrast agent requirements; 2) low-contrast
TAVR can minimize the risk of AKI; and 3) this strategy is
safe and can improve the outcome of TAVR.
Sixty consecutive patients underwent transfemoral or transapical
TAVR. In all patients, Edwards Sapien Transcatheter Heart Valves
(Edwards Lifesciences, Irvine, California) were implanted. Subjects
were randomized in a ratio of 1:1. In group 1, angiography served as
the primary and ICE as the complementary guiding tool. In group
2, TAVR was primarily guided by ICE and complemented by
angiography at the beginning of the procedure. If needed, angiog-
raphy was repeated after valve deployment. Longitudinal views (4)
served as primary ICE views and after deployment, short-axis
views of the prosthetic valve were obtained (Online Video 1). In
group 2, a pigtail catheter advanced into the noncoronary cusp
identiﬁed the level of the valvular annulus. Repeat angiography was
performed as needed only in group 1. AKI was graded as proposed
by the Valve Academic Research Consortium (5).B
zp ¼ 0.27, xp ¼ 0.02, kp ¼ 0.01, and mean D ¼ 0.34 mg/dl (95% conﬁdence
p differences on day 30: *p ¼ 0.21, yp ¼ 0.23, zp ¼ 0.18, xp ¼ 0.01, kp ¼ 0.03, and
stments for multiple comparisons were made. Please see Online Videos 1 and 2.
Letters to the Editor J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 3 , 2 0 1 4
M A R C H 2 0 1 4 : 3 1 3 – 2 3
320The patients represent a high-risk population (Logistic Euro-
SCORE 31.6  13.2%, Society of Thoracic Surgeons score 12.6 
4.7%). Groups did not differ in terms of age, sex, operative risk
scores, body mass index, comorbidities, disease-related parameters,
pharmacotherapy, blood transfusion, prosthetic valve size, number
of pelvic angiographies, and type of access. No patient was on long-
term dialysis before the intervention. Device success was achieved in
all patients without intraprocedural deaths. With 2 deaths each, 30-
day mortality was not different between groups. The amount of
contrast agent used was markedly lower in group 2 (72.0  30.7 ml
vs. 20.1  8.7 ml; mean D ¼ 51.9 ml [95% conﬁdence interval
(CI): 60.6 to 43.3]). Post-procedural in-hospital stay was shorter
in group 2 (mean D ¼ 3.7 days [95% CI: 5.7 to 1.6]).
Creatinine levels and estimated glomerular ﬁltration rate did not
differ until days 3 and 30 (Fig. 1). Serum creatinine levels in group 1
were higher on day 3 than baseline levels (1.63  0.95 mg/dl vs.
1.05 0.27 mg/dl, p< 0.001), but not in group 2 (1.15 0.55 mg/dl
vs. 1.04  0.28 mg/dl, p ¼ 0.209). In parallel, on day 3, the esti-
mated glomerular ﬁltration rate was only decreased in group 1
(group 1: 47.1  23.2 mg/dl vs. 57.4  21.6 mg/dl, p ¼ 0.009;
group 2: 64.7  29.8 mg/dl vs. 64.1  19.0 mg/dl, p ¼ 0.861). The
risk of the development of stage 3 AKI was lower in group 2 (odds
ratio: 0.47; 95% CI: 0.36 to 0.62). The proportion of patients with
stage 0 AKI was higher in group 2 (80% vs. 63%), whereas the risk
of the development of stage 2 and 3 AKI was lower (7% vs. 23%);
the chi-square test for trend revealed borderline signiﬁcance (p ¼
0.05). The radiocontrast volume requirement decreased to 20.1 
8.7 ml in group 2 (mean D ¼ 61.9 ml [95% CI: 70.6 to 53.3]),
but the risk of procedure-related complications was not higher in
this group (odds ratio: 0.46; 95% CI: 0.10 to 2.05). ICE views
helped position the valve prosthesis properly (Online Video 2). The
use of ICE saved 2 to 6 injections.
This study is limited by its single-center character, making the
results preliminary. The present results do not apply to TAVR
performed with systems other than the Edwards Sapien Trans-
catheter Heart Valve Systems. ICE guidance of TAVR is compat-
ible with monitored anesthesia care in selected patients, reducing
radiocontrast agent requirements, lowering the severity and probably
the rate of AKI, and possibly shortening in-hospital stay after
TAVR in high-risk patients.
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Semiautomated Quantiﬁcation
of Aortic Annulus Dimensions
on Cardiac CT for TAVR
Computed tomography (CT) is increasingly used for prosthesis
sizing in transcatheter aortic valve replacement (TAVR) because it
enables 3-dimensional assessment of the complex aortic root anat-
omy, including the aortic annulus dimensions and the distance from
the coronary artery oriﬁces to the aortic annulus (1,2). CT can
further predict appropriate C-arm angulation for orthogonal pro-
jection of the annulus plane. However, manual determination of
these measurements is cumbersome and time-consuming. Alterna-
tively, 3-dimensional cardiac CT datasets may be analyzed by
automated computational algorithms (3). The aim of this investi-
gation was to evaluate the accuracy and time-effectiveness of sem-
iautomated model-based annulus computation compared with
manual planimetry in TAVR patients.
Of 54 consecutive patients with severe symptomatic aortic ste-
nosis and tricuspid valve anatomy undergoing dedicated
electrocardiography-gated CT for TAVR planning, 4 patients were
excluded due to insufﬁcient image quality and 50 were included in
this analysis (mean age 82.0  5.8 years; mean aortic valve area 0.7
 0.2 cm2). CT data were reconstructed at 300 ms past the R peak
(section thickness, 0.6 mm) and transferred to a dedicated post-
processing workstation equipped with prototype analysis software
(Heart Valve Analysis Protocol, Siemens Healthcare Sector, For-
chheim, Germany) on the basis of a 3-dimensional anatomic model
of the aortic valve (4) (Figs. 1A to 1C). Both manual and semi-
automated assessments were performed independently by 2
observers with 5 years and no experience in interpreting TAVR-
planning CT studies, respectively. The inexperienced observer
was trained on 10 datasets before the study. Each workﬂow was
repeated after a 4-week interval to deﬁne intraobserver variability.
Formanual assessment, CT image data were reformatted to display
the aortic annulus, deﬁned by a plane transecting the basal attachment
points of the aortic cusps. Planimetry of the aortic annulus was per-
formed bymanually tracking the luminal contours, yielding the cross-
sectional area (A) and perimeter (P). The area-derived diameter and
perimeter-derived diameter were calculated (DA ¼ 2  O(A/p) and
DP¼P/p, respectively). The distance from the aortic annulus plane to
the lower edge of the coronary ostia was measured in a perpendicular
fashion. Finally, the corresponding cranial/caudal angulation of the
